VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions.
- Sector(s): Healthcare
- Industry: Biotechnology
- Full Time Employees: 42
- Incorporated in 2019
- Headquartered in Basel, Switzerland
- https://vectivbio.com
VectivBio priced 7.5 mln shares IPO at $17.00 per share, at the midpoint of the $16-18 expected range
No comments:
Post a Comment